Showing results (1-10 of 546) with videos related to

Sort By:
Pageof 55
Haemostasis|March 17, 2001
Physiological function of tissue factor pathway inhibitor and interaction with heparinsP M Sandset, B Bendz, J B Hansen
British Journal of Haematology|December 22, 1999
Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparinsB Bendz, J B Hansen, T O Andersen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparinsB Bendz, T O Andersen, P M Sandset
Thrombosis Research|March 8, 2000
A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1B Bendz, T O Andersen, P M Sandset
British Journal of Haematology|July 23, 1998
Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic actionJ B Hansen, P M Sandset, K R Huseby, et al.
British Journal of Haematology|June 3, 1999
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individualsC Seidel, H Hjorth-Hansen, B Bendz, et al.
Thrombosis Research|September 15, 1998
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacyJ B Hansen, P M Sandset
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 16, 2001
Low molecular weight heparin prevents activation of coagulation in a hypobaric environmentB Bendz, K Sevre, T O Andersen, et al.
Lancet (London, England)|November 23, 2000
Association between acute hypobaric hypoxia and activation of coagulation in human beingsB Bendz, M Rostrup, K Sevre, et al.
Thrombosis Research|January 11, 2001
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombinJ B Hansen, B Svensson, P M Sandset, et al.
Pageof 55